| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |